Clinical Trials Search Results
Results 1-10 of 545 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | "colorectal cancer" |
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1175 locations
Age: 18 years and over
Gender: Male or Female
Location: 1175 locations
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 859 locations
Age: 18 years and over
Gender: Male or Female
Location: 859 locations
Combination Chemotherapy with or without Atezolizumab in Treating Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 838 locations
Age: 18 years and over
Gender: Male or Female
Location: 838 locations
Combination Chemotherapy, Bevacizumab, and / or Atezolizumab in Treating Patients with Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 351 locations
Age: 18 years and over
Gender: Male or Female
Location: 351 locations
Phase 1 / 2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Active
Age: 12 years and over
Gender: Male or Female
Location: 31 locations
Age: 12 years and over
Gender: Male or Female
Location: 31 locations
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1 / 2 / 3 (Trk A / B / C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 28 locations
Age: 18 years and over
Gender: Male or Female
Location: 28 locations
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Savolitinib in Treating Participants with MET Amplified Metastatic or Unresectable Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 21 locations
Age: 18 years and over
Gender: Male or Female
Location: 21 locations
Phase 1 / 1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 21 locations
Age: 18 years and over
Gender: Male or Female
Location: 21 locations
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 20 locations
Age: 18 years and over
Gender: Male or Female
Location: 20 locations